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background information. Data analysis included descriptive sta-
tistics utilizing SPSS. RESULTS: With a usable response rate of
51%, results indicate that most Texas community pharmacists
(91%) had heard of EC, while approximately 45 percent keep
EC in stock. Over half (58%) have dispensed EC, and 95 percent
were aware that EC is most effective when taken within 72
hours. Twenty-seven percent were opposed to dispensing EC.
Additionally, most pharmacists (58%) believed that there should
be a minimum age for patients receiving EC; the average
minimum age indicated was 17.25 years (s.d. = 1.93). Less than
half (47%) of the respondents had heard of PIEC. Pharmacists
indicated that they would be unwilling to participate in PIEC
and were not willing to obtain liability insurance for PIEC. They
indicated that convenience to patients and reducing unwanted
pregnancies were potential beneﬁts of PIEC, while potential bar-
riers included inadequate time for counseling, increased liability,
moral/religious opposition, increase in unprotected sex and sex-
ually transmitted diseases, and fear of overuse. CONCLUSION:
While many community pharmacists in Texas have dispensed
EC, only 47% of respondents had heard of PIEC prior to this
study, and most were unwilling to participate in PIEC. Potential
barriers outweighed potential beneﬁts for most pharmacists
regarding PIEC. Policy efforts to facilitate PIEC should focus on
reducing perceived barriers of community pharmacists.
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OBJECTIVES: An adolescent sexual behaviour survey was
created in English from an extensive literature review and expert
input. This was translated into 11 languages. The objective was
to produce translations that are conceptually equivalent to the
original and to other language versions ensuring the relevance of
the translation within the target cultures. METHODS: A stan-
dard methodology was employed: two forward translations, a
reconciliation of the forward translations, two back translations,
a back translation review, linguistic validation interviews with 5
adolescents in each country, and to proof readings. RESULTS:
Numerous cultural and linguistic issues became apparent
throughout the translation process as follows: The term “sexual
activity” was not universally acceptable. It was changed to “rela-
tions” in Belgium and Turkey, “experience” in Czech, “contact”
in German and “behaviour” in Korea. The term “vaginal sex”
caused some issues in Poland where it is only referred to in this
way by gynecologists and feminists. For vaginal sex “sex” alone
was used. Adolescents in China did not fully understand the term
genital contact and anal sex. Most people are reluctant to talk
about sexual activities other than vaginal sex. In Korea, oral or
anal sex is generally considered as sexual deviation. Female
respondents indicated a lack of knowledge regarding female
condoms in Belgium and Turkey. Female condoms are not avail-
able in Poland and this item was therefore removed from the
Polish version of the questionnaire. CONCLUSIONS: The 
adolescent sexual behaviour survey has been translated and lin-
guistically validated in numerous languages using a rigorous
translation process. A number of cultural and linguistic issues
became apparent and were resolved. The measure could be used
internationally in surveys of adolescent sexual behaviour.
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OBJECTIVES: To develop and validate the Premenstrual Symp-
toms Impact Survey (PMSIS), a brief instrument for evaluating
impact of premenstrual symptoms on quality of life (QOL).
METHODS: An item bank of 73 questions was administered to
a general US sample of women aged 18–45. Item reduction was
performed using forward stepwise linear regression of symptom
severity scores onto item scores. Three standards were used to
validate the instrument: 1) the American College of Obstetricians
and Gynecologists diagnostic criteria for premenstrual syndrome
(PMS); 2) the Diagnostic and Statistical Manual of Mental Dis-
orders diagnostic criteria for premenstrual dysphoric disorder
(PMDD); and 3) feedback from a panel of practicing physicians.
A “known groups” analysis was used to determine discriminant
validity. RESULTS: Six items met entry criteria in the model
using a discrimination cutoff of p < 0.01. The overall ﬁt was sta-
tistically signiﬁcant (F = 279.4; p < 0.001; R2 = 0.64). Approxi-
mately 20.4% of the sample screened positive for PMS and
16.1% screened positive for PMDD. Univariate ANOVA showed
that the PMS positive group (m = 49.2) had a signiﬁcantly larger
PMSIS mean score (0–100 range with greater values indicating
more impact of symptoms on QOL) than the PMS negative
group (m = 20.1) (F = 414.2, p < 0.001). Likewise, the PMDD
positive group (m = 52.3) had a signiﬁcantly larger PMSIS mean
score than the PMDD negative group (m = 21.0) (F = 393.8, p <
0.001). The mean minimum score at which practicing physicians
recommended an ofﬁce visit was 46.7 (SD = 7.1). CONCLU-
SIONS: These results demonstrate that the PMSIS has excellent
discriminative ability to detect differences in groups known to
differ in terms of clinical criteria. As premenstrual symptoms can
signiﬁcantly impact QOL, the PMSIS can be used to educate con-
sumers about the impact of their symptoms on QOL.
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OBJECTIVES: We conducted a large qualitative assessment of
medication taking behavior in BPH patients. METHODS: A
national online survey of 1000BPH sufferers on current or past
treatments was administered to evaluate treatments used, com-
pliance with treatment, and behaviors regarding medication use.
Descriptive analyses were performed and stratiﬁed by demo-
graphic variables including discontinuation, compliance, and
reasons for discontinuation and non-compliance when present.
RESULTS: A total of 734 (73%) patients surveyed were over 60
years of age with the vast majority of the sample 955 (95%)
being caucasian. Data on household income, education, and geo-
graphic region were fairly evenly distributed across the U.S.
Nearly three-quarters of the sample (74%) had BPH symptoms
for 3 years or more. The most commonly used recent medica-
tions were doxazocin, terazocin, alfuzocin, tamsulosin, ﬁnas-
teride, and trospium chloride. Forty four percent of patients had
